Connection

Charles Smith to Cholangiocarcinoma

Back to Details
This is a "connection" page, showing publications Charles Smith has written about Cholangiocarcinoma.
Charles Smith
Connection Strength
0.134
Cholangiocarcinoma
  1. Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells. Oncotarget. 2016 Apr 12; 7(15):20080-92.
    View in: PubMed
    Score: 0.134
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.